诺和诺德加码开发srRNA新药治疗肥胖和糖尿病

动脉网
Sep 01, 2025

诺和诺德与Replicate Bioscience签署5.5亿美元合作协议,共同开发srRNA新药,旨在治疗肥胖、2型糖尿病等心脏代谢疾病,利用srRNA技术提高蛋白质表达,为更多患者提供新治疗机会。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10